Name:	ontx_CollaborativeArrangementAggregatePotentialMilestonePayments
Namespace Prefix:	ontx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

The aggregate amount of payments that could be received based on achievement of annual net sales under the arrangement.

No definition available.

Name:	ontx_CollaborativeArrangementAggregatePotentialMilestonePaymentsBasedOnAnnualNetSales
Namespace Prefix:	ontx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

The cumulative amount of discount on purchases.

No definition available.

Name:	ontx_CollaborativeArrangementCumulativeDiscountOnPurchases
Namespace Prefix:	ontx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

The percentage of discount on future purchases.

No definition available.

Name:	ontx_CollaborativeArrangementPercentageOfDiscountOnFuturePurchases
Namespace Prefix:	ontx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Represents the percentage of royalty payments based on net sales under the arrangement.

No definition available.

Name:	ontx_CollaborativeArrangementPercentageOfRoyaltyPaymentBasedOnNetSales
Namespace Prefix:	ontx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Represents the aggregate amount of payments that could be received upon receipt of marketing approval for additional indications under the arrangement.

No definition available.

Name:	ontx_CollaborativeArrangementPotentialMilestonePaymentsDueUponReceiptOfMarketingApprovalForAdditionalIndication
Namespace Prefix:	ontx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Represents the amount of regulatory milestones payments due upon receipt of marketing approval for indications under the arrangement.

No definition available.

Name:	ontx_CollaborativeArrangementPotentialRegulatoryMilestonePaymentsDueUponReceiptOfMarketingApprovalOfIndication
Namespace Prefix:	ontx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

The period of prior written notice for termination of agreement.

No definition available.

Name:	ontx_CollaborativeArrangementPriorWrittenNoticeForTerminationOfAgreementPeriod
Namespace Prefix:	ontx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the amount of upfront payment paid by the entity under the arrangement.

No definition available.

Name:	ontx_CollaborativeArrangementUpfrontPayment
Namespace Prefix:	ontx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

The excess of the (1) fair value of consideration transferred to the holders of a security in excess of (2) the carrying amount of the security reported on the registrant's balance sheet, which will be deducted from net earnings to derive net earnings available to common shareholders. This amount is generally an adjustment considered in the computation of earnings per share.

No definition available.

Name:	us-gaap_RedemptionPremium
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Number of new stock issued during the period.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Name:	us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementCopromotionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_CounterpartyNameAxis=ontx_SymBioPharmaceuticalsLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_CounterpartyNameAxis=ontx_HanXBiopharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_CounterpartyNameAxis=ontx_PintInternationalSaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_ProductOrServiceAxis=ontx_RigosertibMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_ProductOrServiceAxis=ontx_HanxLicensePaymentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=ontx_SecuritiesPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_StatementGeographicalAxis=ontx_UnitedStatesAndJapanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_StatementScenarioAxis=ontx_RigosertibIntravenousInHigherRiskMyelodysplasticSyndromePatientsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_StatementScenarioAxis=ontx_RigosertibOralInLowerRiskMDSPatientsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: